Stroke characteristics in patients with pretreated arterial hypertension

European Neurology

Volumn 64, Issue 6, 2010, Pages 355-359

  De Reuck, J ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE   (Belgium)

Author keywords

Haemorrhagic stroke; Ischaemic stroke; Pretreated arterial hypertension; Stroke outcome; Stroke severity; Vascular risk factors

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DISABILITY; DISEASE SEVERITY; FEMALE; HEALTH; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; RISK FACTOR; STROKE;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 78149463493     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322139     Document Type: Article

References (26)

1. Wolf PA, Kannel WB, D'Agostino RB: Epidemiology of stroke; in Ginsberg MD, Bogousslavsky J (eds): Cerebrovascular Disease. Pathophysiology, Diagnosis and Management. Malden, Blackwell Science, 1998, pp 834-849.
2. Brown DW, Giles WH, Greenlund KJ: Blood pressure parameters and risk of fatal stroke, NHANES II mortality study. Am J Hypertens 2007; 20: 338-341.
3. Sagie A, Larson MG, Levy D: The natural history of borderline isolated systolic hypertension. N Eng J Med 1993; 329: 1912-1917. (Pubitemid 24003117)
4. Perry HM Jr, Miller JP, Baty JD, Carmody SE, Sambhi MP: Pretreatment blood pressure as a predictor of 21-year mortality. Am J Hypertens 2000; 13: 724-733.
5. Li C, Engstrom G, Berglund G, Janzon L, Hedblad B: Incidence of ischemic stroke in relation to asymptomatic carotid artery atherosclerosis in subjects with normal blood pressure. A prospective cohort study. Cerebrovasc Dis 2008; 26: 297-303.
6. Bestehorn K, Wahle K, Kirch W: Stroke risk screening of adults with hypertension: prospective cross-sectional study in primary care. Clin Drug Investig 2008; 28: 281-289.
7. Filippi A, Palini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O: Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. J Hum Hypertens 2009; 23: 758-763.
8. Goldstein LB, Bertels C, Davis JN: Interrater reliability of the NIH stroke scale. Arch Neurol 1989; 46: 660-662.
9. Uyttenbogaart M, Luijckx GJ, Vroomen PC, Stewart RE, De Keyser J: Measuring disability in stroke: relationship between the modified Rankin scale and the Barthel index. J Neurol 2007; 254: 1113-1117.
10. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-1526.
11. De Reuck J, Vervaet V, Van Maele G, De Groote L: Short-term outcome of patients with cardiac- and thromboembolic cerebral infarcts. Clin Neurol Neurosurg 2008; 110: 566-569.
12. Thomas F, Blacher J, Benetos A, Safar ME, Pannier B: Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality. J Hypertens 2008; 26: 1072-1077.
13. De Simone G, Izzo R, Chinali M, De Marco M, Casainuovo G, Rozza F, Girgoglio D, Iovino GL, Trimarco B, De Luca N: Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 2010; 56: 99-104.
14. Fourrier-Réglat A, Cuong HM, Lassalle R, Depont F, Robinson P, Droz-Perroteau C, Pariente A, Bégaud B, Blin P, Moore N: Concordance between prescriber- and patientreported previous medical history and NSAID indication in the CADEUS cohort. Pharmacoepidemiol Drug Saf 2010; 19: 474-481.
15. Missault L, Witters N, Imschoot J: High cardiovascular risk and poor adherence to guidelines in 11,069 patients of middle age and older in primary care centres. Eur J Cardiovasc Prev Rehabil 2010; 17: 593-598.
16. European Stroke Organization (ESO) Executive Committee; ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 2008; 25: 457-507.
17. PROGRESS Collaborative Group: Randomized trial of a perindopril-based blood-pressure- lowering regime among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041.
18. Santalucia P: Intracerebral hemorrhage: medical treatment. Neurol Sci 2008; 29(suppl 2):S271-S273.
19. Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of ACE inhibitors, calcium antagonists, and other blood-pressurelowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000; 356: 1955-1964.
20. Dahlof B, Devereux RB, Kjedsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Leberballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparl S, Wedel H, LIFE Study Group: Cardiovascular morbidity and mortality in the Losartan Intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003. (Pubitemid 34286536)
21. Calvet D, Touzé E, Varenne O, Sablayrolles JL, Weber S, Mas JL: Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation 2010; 121: 1623-1629.
22. Deplanque D, Leys D, Parnetti L, Schmidt R, Ferro J, De Reuck J, Mas JL, Gallai V, the SAFE II Investigators: Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol 2004; 57: 798-806.
23. Deplanque D, Leys D, Parnetti L, Schmidt R, Ferro J, De Reuck J, Mas JL, Gallai V: Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge. Cerebrovasc Dis 2006; 21: 372-379.
24. Bi Q, Wang L, Li X, Song Z: Risk factors and treatment of stroke in Chinese young adults. Neurol Res 2010; 32: 363-370.
25. Lee K: Cardiovascular risk prevalence, awareness, treatment, and control from 1998 to 2007 in Koreans. Asia Pac J Clin Nutr 2010; 19: 261-265.
26. Brenner DA, Zwelfler RM, Gomez CR, Kissela BM, Levine D, Howard G, Coull B, Howard VJ: Awareness, treatment, and control of vascular risk factors among stroke survivors. J Stroke Cerebrovasc Dis 2010; 19: 311-320.